Company news
Jupiter Neurosciences, Inc. news in 2025
Jupiter Neurosciences, Inc.'s news releases, calls and decks from 2025, newest first.
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6
December 23, 2025
Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum
December 3, 2025
Jupiter Neurosciences to Participate in NobleCon21
December 2, 2025
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
November 5, 2025
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
November 5, 2025
Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing
October 27, 2025
Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador
September 15, 2025
Jupiter Neurosciences Launches Nugevia™ Website and Opens Pre-Orders for Groundbreaking Longevity Supplements
August 26, 2025
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador
August 19, 2025
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
August 18, 2025
Jupiter Neurosciences Introduces Nugevia™ MND: A Cognitive Health Supplement Leveraging Clinically Validated Neuroscience
August 11, 2025
Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science
July 23, 2025
Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 10, 2025
Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery
June 30, 2025
Jupiter Neurosciences Unveils Nugevia™ GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Science
June 27, 2025
Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador
June 23, 2025
Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science
June 9, 2025
Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter
April 8, 2025
Jupiter Neurosciences and Aquanova AG Announce Strategic Collaboration to Develop Longevity and Healthspan Products
March 4, 2025
Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones
February 3, 2025
Jupiter Neurosciences Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson’s Trial
February 2, 2025
Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
January 29, 2025
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
January 12, 2025
Decks in 2025
- Investor Presentation (2025)
Investor deck · 10 slides · Dec 9, 2025
- Investor Presentation (February 2025)
Investor deck · 18 slides · February 2025